Updated Jul 16, 2026
Kariuki Enoch has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Based on SEC filings, Kariuki Enoch is listed as a director of Zentalis Pharmaceuticals, Inc. as of June 18, 2026. No additional publicly available biographical details are evident from the SEC filing context alone.
| Role | Director |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | ZNTL | Zentalis Pharmaceuticals, Inc. | A — Grant or award | 57.1K | $0.00 |
Based on SEC filings, Kariuki Enoch is listed as a director of Zentalis Pharmaceuticals, Inc. as of June 18, 2026. No additional publicly available biographical details are evident from the SEC filing context alone.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kariuki Enoch profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.